Thrombotic Microangiopathy in Interferon-beta-Treated Multiple Sclerosis Patient

Masoud Mohammad Malekzadeh1, Reza Alizadeh2, Ziba Aghsaeifard3,4

  • 1Digestive Disease Research Center Digestive Disease Research Institute Shariati Hospital Tehran University of Medical Sciences Tehran Iran.

Clinical Case Reports
|June 25, 2020
PubMed
Summary

Interferon-beta treatment for multiple sclerosis can cause severe side effects including hypertension and renal dysfunction. Prompt medical intervention with drugs and dialysis is crucial for symptom relief.